Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles: studies of human UDP-glucuronosyltransferases involved and substrate specificities.

A series of eight 1-substituted imidazoles was investigated as model substrates for glucuronidation at an aromatic tertiary amine of polyaza heterocyclic ring systems. The human UDP-glucuronosyltransferases (UGTs) involved and substrate specificities were investigated. Nine expressed enzymes (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A9, UGT1A10, UGT2B7, and UGT2B15) were examined, but only UGT1A4 catalyzed the formation of a quaternary ammonium-linked glucuronide metabolite for six of the substrates. UGT1A3 also catalyzed the glucuronidation of the previously investigated 1-phenylimidazole but none of the newly investigated compounds. No glucuronidation was observed with 1-(4-nitrophenyl)imidazole, the compound with the 4-phenyl substituent with the largest electron withdrawing effect. The incubation conditions for the determination of the kinetic constants for UGT1A4 catalysis of six substrates were optimized and included incubation at pH 7.4 with alamethicin at 10 microg/mg of protein. Latency disrupting agents, including alamethicin and sonication, enhanced glucuronidation 1.25-fold at most. There were 17.5- and 2.2-fold variations in the apparent K(m) (range, 0.18-3.15 mM) and V(max) values (range, 0.16-0.35 nmol/min/mg of protein). Linear correlation analyses between UGT1A4 kinetics and substrate physicochemical parameters showed significant correlation between V(max) and both the partition coefficient (log P, n-octanol/water) and pK(a) and between K(m) and pK(a), thereby indicating that the lipophilicity and the ease of availability of the tertiary amine lone pair of electrons of the substrate are important with respect to enzyme catalysis.

[1]  M. Green,et al.  Studies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes. , 1992, Drug Metabolism And Disposition.

[2]  M. Green,et al.  Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[3]  K H Kim,et al.  Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase. , 1991, Journal of pharmaceutical sciences.

[4]  P. Crooks,et al.  Characterization of the glucuronide conjugate of cotinine: a previously unidentified major metabolite of nicotine in smokers' urine. , 1992, Chemical research in toxicology.

[5]  C. Larsen,et al.  Metabolism and excretion of citalopram in man: identification of O-acyl- and N-glucuronides. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[6]  P. van Bladeren,et al.  The metabolic fate of 3[H]econazole in man. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  G. Mckay,et al.  Synthesis and identification of the quaternary ammonium-linked glucuronide of 1-phenylimidazole in human liver microsomes and investigation of the human UDP-glucuronosyltransferases involved. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[8]  M. Green,et al.  Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[9]  J. Magdalou,et al.  In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions. , 1994, The Journal of pharmacology and experimental therapeutics.

[10]  K. Cassidy,et al.  1 H-TETRAZOL-5-YLMETHYL ) PHENYL ] METHOXY ] PHENOXY ] METHYL ] QUINOLINE N-GLUCURONIDATION BY IN VITRO AND IN VIVO APPROACHES , 2001 .

[11]  M. Coughtrie,et al.  Glucuronidation of imipramine in rabbit and human liver microsomes: assay conditions and interaction with other tertiary amine drugs. , 1991, Biochemical pharmacology.

[12]  R. Remmel,et al.  Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[13]  R. Tukey,et al.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.

[14]  M. Tarbit,et al.  Characterization of a quaternary, N-glucuronide metabolite of the imidazole antifungal, tioconazole. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[15]  M. Green,et al.  Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[16]  R. Miller,et al.  N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[17]  R. Miller,et al.  N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[18]  R. Miller,et al.  Synthesis and identification of a novel tetrazole metabolite of the angiotensin II receptor antagonist DuP 753. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[19]  P. Beaune,et al.  Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[20]  M. Green,et al.  Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[21]  S. Huskey,et al.  N-Glucuronidation of Xenobiotics Symposium SPECIES DIFFERENCES IN N-GLUCURONIDATION , 1998 .

[22]  V. Sorrenti,et al.  N-Substituted-imidazoles as Inhibitors of Nitric Oxide Synthase: A Preliminary Screening. , 2010 .

[23]  E. Hawes N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[24]  D. J. Graham,et al.  The metabolism of imiloxan hydrochloride in healthy male volunteers. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  M. Green,et al.  Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[26]  K. Mizojiri,et al.  Quaternary ammonium glucuronide of croconazole in rabbits. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[27]  A. Colletti,et al.  Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[28]  G. Siest,et al.  N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[29]  J. Magdalou,et al.  Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers. , 1999, The Journal of pharmacology and experimental therapeutics.

[30]  H. Wachsmuth,et al.  Conjugation of the enantiomers of ketotifen to four isomeric quaternary ammonium glucuronides in humans in vivo and in liver microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[31]  G. Siest,et al.  In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. , 1992, The Journal of pharmacology and experimental therapeutics.

[32]  M. Kuo,et al.  Isolation and identification of a major metabolite of PNU-107859, an MMP inhibitor from the biliary fluid of rats. , 1999, Journal of Pharmacy and Science.

[33]  D. Fischer,et al.  Biphasic kinetics of quaternary ammonium glucuronide formation from amitriptyline and diphenhydramine in human liver microsomes. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[34]  D. J. Graham,et al.  The metabolism of nafimidone hydrochloride in the dog, primates and man. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[35]  L. Bertilsson,et al.  Formation of a quaternary N-glucuronide of amitriptyline in human liver microsomes. , 1987, Pharmacology & toxicology.

[36]  D. R. Hawkins,et al.  The metabolic fate of (3H)econazole in man , 1981 .